DGAP-News

Aladdin Healthcare Technologies completes Biomedical Knowledge Graph for Commercial use In Drug Development - Seite 2

About Aladdin Healthcare Technologies SE
Aladdin Healthcare Technologies SE (and its wholly owned subsidiary Aladdin Healthcare Technologies Ltd.) is a leading developer of AI healthcare diagnostics and drug discovery applications that can accelerate both early stage disease diagnosis and the end-to-end drug discovery process. Aladdin targets age-related diseases including a significant focus on Alzheimer's disease. Aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to confidentially and securely gather targeted data including, genome, tabular, MRI, PET, cognition and other lifestyle data. These datasets are then analysed by our award-winning AI team and used to develop proprietary AI tools that can assist healthcare professionals to more accurately and efficiently diagnose age-related diseases. This new diagnostic process will save significant time and costs for healthcare professionals. Additionally, our AI drug discovery platform will be used by pharmaceutical Companies to speed up drug development, clinical trials and predict outcomes more accurately.

Website Link: www.aladdinid.com
GSIN: A12ULL
ISIN: DE000A12ULL2
TICKER SYMBOL: NMI

For further information:

Aladdin Healthcare Technologies Ltd.
24-26 Baltic Street West
London EC1Y 0UR
Phone [phone]
Email: [e-mail]

Contact Press
CROSS ALLIANCE communication GmbH
Sara Pinto
Phone [phone]
Email: [e-mail]
www.crossalliance.de

---

21.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---

Language:	English
Company:	Aladdin Healthcare Technologies SE
	Unter den Linden 10
	10117 Berlin
	Germany
Phone:	030 700140449
E-mail:	[e-mail]
Internet:	www.aladdinid.com
ISIN:	DE000A12ULL2
WKN:	A12ULL
Listed:	Regulated Market in Dusseldorf
EQS News ID:	1134001